Biotech China 2014
Predictive Preclinical Models in Oncology
Moscone North Convention Center

San Francisco, CA USA
http://www.triconference.com/mmtc_content.aspx?id=130008&libID=129956
Predictive Preclinical Models in Oncology
Cambridge Healthtech Institute
http://www.triconference.com/mmtc_content.aspx?id=130008&libID=129956
Moscone North Convention Center 
San Francisco
CA USA

Schedule of Presentations:

Monday, February 10, 2014
02:15:00 Session Break
11:50:00 Chairperson’s Opening Remarks
12:00:00 Modeling Efficacy and Resistance of Hedgehog Pathway Inhibitors in Cancer Frederic J. de Sauvage
12:30:00 Bridging Tumor Genomics to Therapeutics through Patient Derived Xenografts (PDXs) David R. Gandara
13:00:00 Session Break
13:15:00 Luncheon Presentation I: The ‘Innovation Universe’ at Oncotest
13:45:00 Luncheon Presentation II (Sponsorship Opportunity Available)
14:30:00 Chairperson’s Remarks
14:35:00 Microenvironmental Regulation of GBM Progression and Therapeutic Resistance Gabrielle Bergers
15:05:00 Resistance to MAPK Pathway Inhibitors in Melanoma: Insights and Future Challenges Jessie Villanueva
15:35:00 PANEL DISCUSSION: Translational Oncology Starts from Predictive Preclinical Models Panelists: Speakers of the Day
16:05:00 Utilization of Predictive Champions TumorGraft Models to Guide Oncology Drug Development
16:35:00 Using Populations of Targeted PDX Models to Support Preclinical Trials of Oncology Therapeutics
16:50:00 Refreshment Break and Transition to Plenary Keynote
17:00:00 Plenary Keynote Session (Click Here For More Details)
18:15:00 Grand Opening Reception in the Exhibit Hall with Poster Viewing
19:45:00 Close of Day
Tuesday, February 11, 2014
05:20:00 Breakout Discussions in the Exhibit Hall
07:00:00 Registration and Morning Coffee
08:00:00 PLENARY KEYNOTE SESSION (Click Here For More Details)
09:15:00 Refreshment Break in the Exhibit Hall with Poster Viewing
10:25:00 Chairperson’s Remarks
10:30:00 Pfizer’s Strategy for the Application of Preclinical Models to Fuel Discovery Biology and Drug Discovery Peter Olson
11:00:00 Biomarker-Guided Breast Cancer Drug Evaluation in I-SPY 2 Laura van ‘ t Veer
11:30:00 Preclinical Models to Help Identify Responder Populations in the Clinic
12:00:00 Found in Translation: Patient-Derived Xenograft Models Define Molecular Signatures of Metastasis and Therapeutic Targets Fredika M. Robertson
12:30:00 Session Break
12:40:00 Luncheon Presentation I: Creating a Functional Human Immune System in Mice to Better
13:10:00 Luncheon Presentation II (Sponsorship Opportunity Available)
13:40:00 Refreshment Break in the Exhibit Hall with Poster Viewing
14:15:00 Chairperson’s Remarks Serguei Kozlov
14:20:00 PREDECT in Europe: Goals and Outcomes ralph graeser
14:50:00 Increasing Predictability of Tumor Animal Models via Systematic Validation Terry Van Dyke
15:20:00 Preclinical and Clinical Applications of Patient Derived Xenograft (PDX) Models
15:50:00 PANEL DISCUSSION: Challenging Cancer Heterogeneity with Reproducible and Predictive Preclinical Studies Terry A. Van Dyke
16:20:00 Valentine’s Day Celebration in the Exhibit Hall with Poster Viewing
18:30:00 Close of Day
Wednesday, February 12, 2014
07:00:00 Breakfast Presentation (Sponsorship Opportunity Available) or Morning Coffee
08:00:00 Plenary Keynote Session (Click Here For More Details)
09:45:00 Refreshment Break and Poster Competition Winner Announced in the Exhibit Hall
10:35:00 Chairperson’s Remarks Tom Metcalfe
10:40:00 Targeting Cancer with BiTE™ Molecules Holger Wesche
11:10:00 Molecular Analysis of Mouse Syngeneic Tumor Models as a Translational Tool in Understanding Anti-PD1 Immunotherapy
11:40:00 Missing The Targets: Why In Vivo Models Are Not Up To The Job Bent Jakobsen
12:10:00 Session Break
12:20:00 Luncheon Presentation (Sponsorship Opportunity Available) or Lunch on Your Own
13:00:00 Refreshment Break in the Exhibit Hall and Last Chance for Poster Viewing
13:40:00 Chairperson’s Remarks
13:45:00 Modeling Tumor Heterogeneity: Accounting for CSCs and the Immune System Elaine Hurt
14:15:00 Integration of Cell Line Sensitivity and Genomic Profiling Data for Patient Stratification
14:45:00 Paradoxical Acceleration of Pancreatic Tumorigenesis through Smoothened Inhibition: A Post-Clinical Trial in Genetically Engineered Mice Kenneth Olive
15:15:00 Sponsored Presentations (Opportunities Available)
15:45:00 Refreshment Break
16:00:00 Chairperson’s Remarks
16:05:00 Development of a Clinically Relevant Model of Metastatic Colorectal Cancer Kevin G. Leong
16:35:00 Impact of Aging and Body Fat on Outcome in Preclinical Cancer Models William J. Murphy
17:05:00 Increasing the Breadth and the Bandwidth of Preclinical Assessment in Biologically Engineered Murine Cancer Models Serguei Kozlov
17:35:00 Close of Conference Program
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.